Edwards Lifesciences CorporationEWNYSE
Loading
Net Income ContractionContracting
Percentile Rank71
3Y CAGR-11.0%
5Y CAGR+5.4%
Year-over-Year Change
Total earnings after all expenses, taxes, and interest
3Y CAGR
-11.0%/yr
vs +20.5%/yr prior
5Y CAGR
+5.4%/yr
Recent deceleration
Acceleration
-31.5pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $1.07B | -74.3% |
| 2024 | $4.17B | +197.7% |
| 2023 | $1.40B | -7.9% |
| 2022 | $1.52B | +1.3% |
| 2021 | $1.50B | +82.5% |
| 2020 | $823.40M | -21.3% |
| 2019 | $1.05B | +45.0% |
| 2018 | $722.20M | +16.1% |
| 2017 | $622.10M | +9.2% |
| 2016 | $569.50M | - |